share_log

HC Wainwright & Co. Maintains Buy on Travere Therapeutics, Maintains $17 Price Target

Moomoo 24/7 ·  Mar 13 09:45

HC Wainwright & Co. analyst Ed Arce maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $17 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment